Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
- PMID: 28261385
- PMCID: PMC5316848
- DOI: 10.4254/wjh.v9.i5.278
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
Abstract
Aim: To investigate the relationship between vitamin D and liver fibrosis in hepatitis C-monoinfected or hepatitis C virus (HCV)-human immunodeficiency virus (HIV) co-infected patients.
Methods: Pertinent studies were located by a library literature search in PubMed/Embase/Cochrane/Scopus/LILACS by two individual reviewers. Inclusion criteria: (1) studies with patients with HCV or co-infected HCV/HIV; (2) studies with patients ≥ 18 years old; (3) studies that evaluated liver fibrosis stage, only based on liver biopsy; and (4) studies that reported serum or plasma 25(OH)D levels. Studies that included pediatric patients, other etiologies of liver disease, or did not use liver biopsy for fibrosis evaluation, or studies with inadequate data were excluded. Estimated measures of association reported in the literature, as well as corresponding measures of uncertainty, were recorded and corresponding odds ratios with 95%CI were included in a meta-analysis.
Results: The pooled data of this systematic review showed that 9 of the 12 studies correlated advanced liver disease defined as a Metavir value of F3/4 with 25(OH) D level insufficiency. The meta-analysis indicated a significant association across studies.
Conclusion: Low vitamin D status is common in chronic Hepatitis C patients and is associated with advanced liver fibrosis.
Keywords: Chronic hepatitis C; Hepatitis C virus; Liver fibrosis; Vitamin D.
Conflict of interest statement
Conflict-of-interest statement: All the authors declare that they have no competing interests.
Figures



Similar articles
-
Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data.World J Hepatol. 2018 Jan 27;10(1):142-154. doi: 10.4254/wjh.v10.i1.142. World J Hepatol. 2018. PMID: 29399288 Free PMC article.
-
Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.J Hepatol. 2011 Oct;55(4):756-61. doi: 10.1016/j.jhep.2011.01.041. Epub 2011 Feb 18. J Hepatol. 2011. PMID: 21334402 Clinical Trial.
-
Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.Ont Health Technol Assess Ser. 2010;10(4):1-56. Epub 2010 Mar 1. Ont Health Technol Assess Ser. 2010. PMID: 23074407 Free PMC article.
-
Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysis.J Infect. 2020 Oct;81(4):585-599. doi: 10.1016/j.jinf.2020.06.025. Epub 2020 Jun 15. J Infect. 2020. PMID: 32553842
-
Association between vitamin D and hepatitis C virus infection: a meta-analysis.World J Gastroenterol. 2013 Sep 21;19(35):5917-24. doi: 10.3748/wjg.v19.i35.5917. World J Gastroenterol. 2013. PMID: 24124339 Free PMC article. Review.
Cited by
-
Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial.PeerJ. 2021 Feb 9;9:e10709. doi: 10.7717/peerj.10709. eCollection 2021. PeerJ. 2021. PMID: 33614272 Free PMC article. Clinical Trial.
-
Lack of vitamin D signalling per se does not aggravate cardiac functional impairment induced by myocardial infarction in mice.PLoS One. 2018 Oct 1;13(10):e0204803. doi: 10.1371/journal.pone.0204803. eCollection 2018. PLoS One. 2018. PMID: 30273386 Free PMC article.
-
The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection.PLoS One. 2020 Aug 21;15(8):e0237840. doi: 10.1371/journal.pone.0237840. eCollection 2020. PLoS One. 2020. PMID: 32822420 Free PMC article.
-
Controversial Effects of Vitamin D and Related Genes on Viral Infections, Pathogenesis, and Treatment Outcomes.Nutrients. 2020 Mar 30;12(4):962. doi: 10.3390/nu12040962. Nutrients. 2020. PMID: 32235600 Free PMC article. Review.
-
Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data.World J Hepatol. 2018 Jan 27;10(1):142-154. doi: 10.4254/wjh.v10.i1.142. World J Hepatol. 2018. PMID: 29399288 Free PMC article.
References
-
- Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: global epidemiology and strategies for control. Clin Microbiol Infect. 2016;22:833–838. - PubMed
-
- Shin EC, Sung PS, Park SH. Immune responses and immunopathology in acute and chronic viral hepatitis. Nat Rev Immunol. 2016;16:509–523. - PubMed
-
- Kim WR, Smith JM, Skeans MA, Schladt DP, Schnitzler MA, Edwards EB, Harper AM, Wainright JL, Snyder JJ, Israni AK, et al. OPTN/SRTR 2012 Annual Data Report: liver. Am J Transplant. 2014;14 Suppl 1:69–96. - PubMed
-
- Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet. 2003;362(9401):2095–2100. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous